Global hepatitis report 2026
Overview
The Global hepatitis report 2026 provides the most comprehensive and up-to-date assessment of the global burden of hepatitis B (HBV) and hepatitis C (HCV), which together account for more than 95% of deaths related to viral hepatitis. Despite being preventable and treatable, viral hepatitis remains one of the leading infectious disease killers worldwide.
The report also highlights the progress in response efforts at global, regional and country levels, in the context of global commitments, strategies and targets.
The report is organized around 4 major topics:
- An overview of global commitments, strategies and targets related to viral hepatitis;
- The status of the HBV and HCV epidemics and trends in the period 2015–2024;
- Progress in coverage of interventions for prevention, diagnosis and treatment; and
- Priorities for action at global and regional levels to accelerate progress towards the 2030 elimination targets, and associated country examples.
The report is primarily based on data compiled from Member States in periodic rounds of global hepatitis data collection managed by WHO and model-based estimates of incidence, prevalence and mortality. In the 2025 round, 140 WHO Member States reported data, an increase from 113 in the previous round in 2023. Additional data sources include the WHO Global Health Observatory and databases managed by other UN agencies.
